Diet Therapy in Children with Hypercholesteremia
https://doi.org/10.15690/vsp.v19i4.2140
Abstract
High cholesterol level in serum (especially low-density lipoprotein cholesterol) is the risk factor of cardiovascular diseases. Thus, timely diagnosis and treatment of hypercholesterolemia in children is crucial. The basic treatment for children with hypercholesterolemia is diet therapy. This article analysed current recommendations on nutrition for children with hypercholesterolemia. Cholesterol dietary intake should be limited (< 200–300 mg/day), as well as saturated and hydrogenated fats (up to 8–10%). On the other hand, consumption of mono- (> 10%) and polyunsaturated fatty acids (up to 7–10% of the total dietary calories) should be increased. The need of complex carbohydrates consumption is stated, with the obligatory inclusion of soluble dietary fibres (pectin, inulin, mucus, gum) from fruits, vegetables, beans and whole grains with maintaining normal dietary calories.
Supporting agencies: The article has been funded by JSC «PROGRESS»
About the Author
Aelita A. Kamalova
Kazan State Medical University
Russian Federation
Kazan
Disclosure of interest: Aelita A. Kamalova — receiving fees for lecturing from JSC «PROGRESS».
Russian Federation
Kazan
Disclosure of interest: Aelita A. Kamalova — receiving fees for lecturing from JSC «PROGRESS».
References
1. Allender S, Scarborough P, Peto V, et al. European cardiovascular disease statistics. 2008 ed. European Heart Network; 2008.
2. Sadykova DI. Prophylaxis of obesity in childhood. Prakticheskaya meditsina. 2013;(6 (75)):25–29. (In Russ).
3. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2012;19(4):585– 667. doi: 10.1177/2047487312450228.
4. Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058. doi: 10.1093/eurheartj/ehw272.
5. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381. doi: 10.1093/eurheartj/ehw106.
6. Ezhov MV, Sergienko IV, Rozhkova TA, et al. Russian Guidelines on Familial Hypercholesterolemia Diagnosis and Treatment. Ateroskleroz i dislipidemii. 2016;(4(25)):21–29. (In Russ).
7. Ezhov MV, Sergienko IV, Aronov DM, et al. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis: Russian recommendations VI revision Ateroskleroz i dislipidemii. 2017;(3(28)):5–22. (In Russ).
8. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. National Heart, Lung and Blood Institute. Pediatrics. 2011;128(Suppl. 5):S213–S256. doi: 10.1542/peds.2009-2107C.
9. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122(1):198–208. doi: 10.1542/peds.2008-1349.
10. McCrindle BW, Urbina EM, Dennison BA, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948–1967. doi: 10.1161/CIRCULATIONAHA.107.181946.
11. de Ferranti SD, Newburger JW. Dyslipidemia in children: Management. Official reprint from UpToDate www.uptodate.com ©2020 UpToDate [about 1 p.]. Available online: https://www.uptodate.com/contents/dyslipidemia-in-children-management. Accesses on July 28, 2020.
12. Beaumont JL, Carlson LA, Cooper GR, et al. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915.
13. Frederikson DS, Lees RS. A System for Phenotyping Hyperlipoproteinemia. Circulation. 1965;XXXI(3):321–327. doi: 10.1161/01.cir.31.3.321.
14. Berezin AE. Klinicheskaya lipidologiya. Sovremennaya strategiya diagnostiki, profilaktiki i lecheniya giperlipidemii. Kiev: MORION: 2010. (In Russ).
15. Pediatric nutrition in practice. Koletzko B, vol. ed., Bhatia J, Bhutta ZA, Cooper P, et al., co-eds. 2nd, revised ed. 2015. Available online: https://www.nestlenutrition-institute.org/docs/default-source/global-dcoument-library/publications/secured/pediatric-nutrition-in-practice-volume-2d6c9e1dc43e563eca373ff07002886dc.pdf. Accesses on July 28, 2020.
16. Yusuf S., Hawken S., Ounpuu S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952. doi: 10.1016/S0140-6736(04)17018-9.
17. Catapano A., Reiner Z, De Backer G, et al. EAS/EAS Guidelines for the management of dyslipidemias. The Task Force for the management of dyslipideamias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):S1–S44. doi: 10.1016/j.atherosclerosis.2011.06.028.
18. De Ferranti SD, Steinberger J, Ameduri R, et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association. Circulation. 2019;139(13): e603–e634. doi: 10.1161/CIR.0000000000000618.
19. Turti TV, Namazova-Baranova LS, Borovik TE, et al. The possibilities of diet prophylaxis of atopy in children at the period of additional feeding introduction. Voprosy sovremennoi pediatrii — Current Pediatrics. 2012;11(4):38–46. (In Russ). doi: 10.15690/vsp.v11i4.357
20. NamazovaBaranova LS, Turti TV, Snovskaya MA, et al. Assessment of Tole rability and Safety of Monocomponent Complementary Food Products in the Diet of Infants With Risk for Allergic Diseases. Voprosy sovremennoi pediatrii — Current Pediatrics. 2016;15(2):154–160. (In Russ). doi: 10.15690/vsp.v15i2.1533
21. Turti TV, Makarova SG, Zimina YeP. Allergy Prevention in Children during the Introduction of Complementary Feeding Products. Voprosy sovremennoi pediatrii — Current Pediatrics. 2014;13(6):52–56. (In Russ). doi: 10.15690/vsp.v13i6.1202.
22. Programma optimizatsii vskarmlivaniya detei pervogo goda zhizni v Rossiiskoi P78 Federatsii: metodicheskie rekomendatsii. FGAU «NMITs zdorov’ya detei» Minzdrava Rossii. Moscow; 2019. (In Russ). Available online: http://nczd.ru/wp-content/uploads/2019/12/Met_rekom_1_god_.pdf. Accessed on 28.07.2020.
23. Dietologiya. 4th ed. Baranovskiy AYu, ed. St. Petersburg: Piter; 2012. (In Russ).
24. Marino L., Meyer R., Kruizenga H., Wierdsma N. Dietetic Pocket Guide Paediatrics. Amsterdam: VU University Press; 2019.
25. Fats. In: Dietary Guidelines for Americans 2005. Department of Health and Human Services; Department of Agriculture; 2005. Ch. 6. Available online: https://health.gov/sites/default/files/2020-01/DGA2005.pdf. Accessed on July 28, 2020.
26. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group f or the DISC Collaborative Research Group. JAMA. 1995;273(18): 1429–1435. doi: 10.1001/jama.1995.03520420045036.
27. Tonstad S, Knudtzon J, Sivertsen M, et al. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr. 1996;129(1):42–49. doi: 10.1016/s0022-3476(96)70188-9.
28. Nupponen M, Pahkala K, Juonala M, et al. Metabolic syndrome from adolescence to early adulthood: effect of infancy-onset dietary counseling of low saturated fat: the Special Turku Coronary Risk Factor Intervention Project (STRIP). Circulation. 2015;131(7): 605–613. doi: 10.1161/CIRCULATIONAHA.114.010532.
29. Kaitosaari T, Ronnemaa T, Raitakari O, et al. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized Special Turku Coronary Risk Factor Intervention Project f or Children (STRIP) study. Circulation. 2003;108(6):672–677. doi: 10.1161/01.CIR.0000083723.75065.D4.
30. Rask-Nissila L, Jokinen E, Ronnemaa T, et al. Prospective, randomized, infancy-onset trial of the effects of a low-saturated-fat, low-cholesterol diet on serum lipids and lipoproteins before school age: The Special Turku Coronary Risk Factor Intervention Project (STRIP). Circulation. 2000;102(13):1477–1483. doi: 10.1161/01.cir.102.13.1477.
31. Brown L, Rosner B, Willet W, Sacks SM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69(1): 30–42. doi: 10.1093/ajcn/69.1.30.
32. Rideout TC, Harding SV, Jones PJ, Fan MZ. Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: current understandings and future research priorities. Vasc Health Risk Manag. 2008;4(5):1023–1033. doi: 10.2147/vhrm.s3512.
33. Kon IYa, Gmoshinskaya MV, Georgieva OV, et al. Use of fresh squeezed juices in the feeding of infants during the first year of life. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of perinatology and pediatrics. 2015;60(4):125–130. (In Russ).
34. Ketomaki AM, Gylling H, Antikainen M, et al. Red cell and plasma plant sterols are related during consumption of plant stanol and sterol ester spreads in children with hypercholesterolemia. J Pediatr. 2003;142(5):524–531. doi: 10.1067/mpd.2003.193.
35. Dewell A, Hollenbeck PL, Hollenbeck CB. A critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab. 2006:91(3):772–780. doi: 10.1210/jc.2004-2350.
36. Sirtori CR, Galli C, Anderson JW, Arnoldi A. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis. 2009;203(1):8–17. doi: 10.1016/j.atherosclerosis.2008.06.019.
37. Bitzur R. Phytosterols: another way to reduce LDL cholesterol levels. Mezhdunarodnyi zhurnal serdtsa i sosudistykh zabolevanii. 2013;1(1):29–34. (In Russ).
38. Amundsen AL, Ose L, Nenseter MS, et al. Plant sterol esterenriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr. 2002;76(2): 338–344. doi: 10.1093/ajcn/76.2.338.
39. Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with f amilial hypercholesterolemia. J Lipid Res. 1995;36:1807–1812.
40. Jakulj L, Vissers MN, Rodenburg J, et al. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels. J Pediatr. 2006;148(4):495–500. doi: 10.1016/j.jpeds.2005.11.023.
41. de Jongh S, Vissers MN, Rol P, et al. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis. 2003;26(4):343–351. doi: 10.1023/a:1025155002348.
42. Lea LJ, Hepburn PA. Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring pro gramme. Food Chem Toxicol. 2006;44(8):1213–1222. doi: 10.1016/j.fct.2006.01.017.
Review
For citations:
Kamalova A.A. Diet Therapy in Children with Hypercholesteremia. Current Pediatrics. 2020;19(4):309-315. (In Russ.) https://doi.org/10.15690/vsp.v19i4.2140
Views:
1239
Email this article 
